Research on whether hydroxychloroquine can be effective as a preventive measure has only limited results. Given that the drug may have serious side effects, medical experts strongly warn them not to prescribe this drug to patients as a preventive measure.
"In my opinion, this is a crazy thing," said David Juurlink, the clinical director. University of Toronto Pharmacology. "If the medicine has no side effects, it would be a reasonable thing."
Ace seems to be the part of the population most likely to take the medicine in this way. According to records released by the White House after a medical examination in 2018, the president suffered from a common heart disease and plaque buildup in blood vessels.
Monday ’s disclosure reinforced Trump ’s contempt and vulnerability since the early days of the pandemic. The president insisted that as the virus continued to spread, the country could reopen business, questioning the number of deaths, and dismissing some of his health advisor's claims. However, he seemed willing to take an unproven drug, and he insisted that the virus would spread to his inner circle.
Trump doctor Sean Conley said that he and the president had “a lot of discussion” on the evidence of hydroxychloroquine.
“We concluded that the potential benefits of treatment outweigh the relative risks,” Conley wrote.
Experts worry that Trump's latest comments will trigger another sprint to snatch hydroxychloroquine. Since the president began hyping the drug as a potential treatment, hydroxychloroquine has been on the FDA ’s shortage list since late March. After Trump's boostism led to a surge in demand, the state pharmacy committee cracked down on the drug last month.
Even before Trump ’s comment, the head of the FDA ’s Drug Office expressed concern about vulnerable patients who depended on the drug earlier Monday.
Janet Woodcock, director of the FDA's Center for Drug Evaluation and Research, said on Twitter: "For them, this is a necessary drug, and if it is not available, it will have terrible consequences.
Trump ’s former secretary of veterans ’affairs, David Shulkin, expressed concern on Twitter
Other health experts worry that Trump is The touted drug will affect the public taking hydroxychloroquine, and there is no data to support its use. Even with another experimental drug, other patients worry that patients will tend to use hydroxychloroquine. Gilead's remdesivir- has shown hope in hospitalized patients.
Aneesh Mehta, an infectious disease doctor at Emory University, said that some patients did not participate in the remdesivir trial he assisted because they wanted to take hydroxychloroquine after reading media reports.